Eric Roeland

5.5k total citations · 2 hit papers
163 papers, 2.5k citations indexed

About

Eric Roeland is a scholar working on Public Health, Environmental and Occupational Health, Oncology and Physiology. According to data from OpenAlex, Eric Roeland has authored 163 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Public Health, Environmental and Occupational Health, 49 papers in Oncology and 47 papers in Physiology. Recurrent topics in Eric Roeland's work include Palliative Care and End-of-Life Issues (48 papers), Nausea and vomiting management (30 papers) and Nutrition and Health in Aging (27 papers). Eric Roeland is often cited by papers focused on Palliative Care and End-of-Life Issues (48 papers), Nausea and vomiting management (30 papers) and Nutrition and Health in Aging (27 papers). Eric Roeland collaborates with scholars based in United States, Canada and United Kingdom. Eric Roeland's co-authors include Thomas W. LeBlanc, D. Joseph, Vickie E. Baracos, Arif H. Kamal, Areej El‐Jawahri, Kari Bohlke, Andrew Bruggeman, Marie Fallon, Charles L. Loprinzi and Thomas J. Smith and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Eric Roeland

149 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Management of Cancer Cachexia: ASCO Guideline

2020 373 citations Eric Roeland, Kari Bohlke et al. Journal of Clinical Oncology profile →
Ponsegromab for the Treatment of Cancer Cachexia

2024 97 citations John D. Groarke, Susie M. Collins et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eric Roeland United States	26	913	874	646	589	563	163	2.5k
Antonio Viganò Canada	29	1.3k 1.4×	1.2k 1.4×	1.3k 1.9×	890 1.5×	631 1.1×	69	3.8k
Edith Pituskin Canada	24	1.1k 1.2×	386 0.4×	1.5k 2.3×	506 0.9×	380 0.7×	110	3.4k
Giampiero Porzio Italy	30	541 0.6×	656 0.8×	646 1.0×	755 1.3×	357 0.6×	118	2.3k
Martin Chasen Canada	30	1.3k 1.4×	532 0.6×	1.8k 2.8×	638 1.1×	756 1.3×	102	4.2k
Trisha F. Hue United States	27	1.2k 1.3×	432 0.5×	3.0k 4.6×	925 1.6×	493 0.9×	50	5.1k
Daniel Santa Mina Canada	28	574 0.6×	269 0.3×	1.4k 2.2×	607 1.0×	637 1.1×	137	2.6k
Deborah Fitzsimmons United Kingdom	26	422 0.5×	307 0.4×	724 1.1×	209 0.4×	525 0.9×	88	2.2k
Paula Jiménez‐Fonseca Spain	29	279 0.3×	404 0.5×	1.5k 2.4×	302 0.5×	298 0.5×	186	2.7k
Jie Willey United States	29	353 0.4×	1.0k 1.2×	1.3k 2.1×	785 1.3×	249 0.4×	60	3.2k
Alan K. Hatfield United States	25	438 0.5×	982 1.1×	1.2k 1.9×	1.1k 1.8×	619 1.1×	55	4.4k

Countries citing papers authored by Eric Roeland

Since Specialization

Citations

This map shows the geographic impact of Eric Roeland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Roeland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Roeland more than expected).

Fields of papers citing papers by Eric Roeland

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Roeland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Roeland. The network helps show where Eric Roeland may publish in the future.

Co-authorship network of co-authors of Eric Roeland

This figure shows the co-authorship network connecting the top 25 collaborators of Eric Roeland. A scholar is included among the top collaborators of Eric Roeland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Roeland. Eric Roeland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yeo, Winnie, Giampaolo Bianchini, Javier Cortés, et al.. (2025). Nausea and vomiting in an evolving anticancer treatment landscape: long-delayed and emetogenic antibody-drug conjugates. Future Oncology. 21(10). 1261–1272.

Navari, Rudolph M., Naoki Inui, Hirotoshi Iihara, et al.. (2025). Individual patient data meta-analysis of NEPA versus aprepitant-based antiemetic regimens for preventing chemotherapy-induced nausea and vomiting. Future Oncology. 21(21). 2823–2833.

Okhuysen, Pablo C., et al.. (2024). The impact of cancer-related diarrhea on changes in cancer therapy. Supportive Care in Cancer. 32(10). 668–668.

Crawford, Jennifer L., John D. Groarke, Susie M. Collins, et al.. (2024). LBA82 Efficacy and safety of ponsegromab, a first-in-class, monoclonal antibody inhibitor of growth differentiation factor 15, in patients with cancer cachexia: A randomized, placebo-controlled, phase II study. Annals of Oncology. 35. S1269–S1269.

Schwartzberg, Lee S., Rudolph M. Navari, Kathryn J. Ruddy, et al.. (2023). Work loss and activity impairment due to extended nausea and vomiting in patients with breast cancer receiving CINV prophylaxis. Supportive Care in Cancer. 31(11). 654–654. 1 indexed citations

Zhu, Xinxia, et al.. (2023). Effect of melanocortin-4 receptor antagonist TCMCB07 on chemotherapy-induced anorexia and weight loss in rats.. Journal of Clinical Oncology. 41(16_suppl). e15196–e15196. 1 indexed citations

Periyakoil, Vyjeyanthi S., Charles F. von Gunten, Éduardo Bruera, David C. Currow, & Eric Roeland. (2022). Symptom Control Research. Journal of Palliative Medicine. 25(10). 1462–1467. 2 indexed citations

Umaretiya, Puja J., Marie Bakitas, Erin R. Currie, et al.. (2022). Missing Voices: Lessons Learned from Nonparticipating Caregivers in Palliative Care Research. Journal of Palliative Medicine. 25(3). 455–460. 1 indexed citations

Boss, Renee D., Claire J. Creutzfeldt, James Fausto, et al.. (2022). Leading from the Heart. Journal of Pain and Symptom Management. 63(6). e645–e646.

10.

Navari, Rudolph M., G. Binder, Alex Molassiotis, et al.. (2022). Duration of Chemotherapy-induced Nausea and Vomiting (CINV) as a Predictor of Recurrent CINV in Later Cycles. The Oncologist. 28(3). 208–213. 7 indexed citations

11.

Best, Till D., Eric Roeland, Nora Horick, et al.. (2021). Muscle Loss Is Associated with Overall Survival in Patients with Metastatic Colorectal Cancer Independent of Tumor Mutational Status and Weight Loss. The Oncologist. 26(6). e963–e970. 18 indexed citations

12.

Hui, David, Kari Bohlke, Ting Bao, et al.. (2021). Management of Dyspnea in Advanced Cancer: ASCO Guideline. Journal of Clinical Oncology. 39(12). 1389–1411. 92 indexed citations

13.

Navari, Rudolph M., et al.. (2021). Single-Dose Netupitant/Palonosetron Versus 3-day Aprepitant for Preventing Chemotherapy-Induced Nausea and Vomiting: A Pooled Analysis. Future Oncology. 17(23). 3027–3035. 13 indexed citations

14.

Navari, Rudolph M. & Eric Roeland. (2020). Unscheduled hydrations: redefining complete response in chemotherapy-induced nausea and vomiting studies. Future Oncology. 16(24). 1863–1872. 2 indexed citations

15.

Vadhan‐Raj, Saroj, Rafat Abonour, Jonathan W. Goldman, et al.. (2017). A first-in-human phase 1 study of a hepcidin monoclonal antibody, LY2787106, in cancer-associated anemia. Journal of Hematology & Oncology. 10(1). 73–73. 75 indexed citations

16.

Garner, Kimberly K., Patricia M. Dubbert, Shelly Lensing, et al.. (2016). Concordance Between Veterans' Self-Report and Documentation of Surrogate Decision Makers: Implications for Quality Measurement. Journal of Pain and Symptom Management. 53(1). 1–4. 8 indexed citations

17.

Curtin, Peter, et al.. (2014). Implementing inpatient, evidence-based, antihistamine-transfusion premedication guidelines at a single academic US hospital. The Journal of Community and Supportive Oncology. 12(2). 56–64. 5 indexed citations

18.

Roeland, Eric, et al.. (2014). Case Report: Efficacy and Tolerability of Ketamine in Opioid-Refractory Cancer Pain. Journal of Pain & Palliative Care Pharmacotherapy. 28(3). 233–242. 14 indexed citations

19.

Joseph, D., Susan Heavey, Carolyn Revta, & Eric Roeland. (2014). Novel investigational biologics for the treatment of cancer cachexia. Expert Opinion on Biological Therapy. 14(8). 1113–1120. 17 indexed citations

20.

Roeland, Eric, et al.. (2010). Symptom control in stem cell transplantation: a multidisciplinary palliative care team approach. Part 1: Physical symptoms.. PubMed. 8(3). 100–16. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact